Gene-based vaccines: recent technical and clinical advances

Trends in Molecular Medicine
J B UlmerMargaret A Liu

Abstract

DNA vaccines have been widely used in efforts to develop vaccines against various pathogens as well as for cancer, autoimmune diseases and allergy. DNA vaccines offer broad efficacy (particularly for their ability to generate both cellular and humoral immunity), ease of construction and manufacture and the potential for world-wide usage even in low-resource settings. However, despite their successful application in many preclinical disease models, their potency in human clinical trials has been insufficient to provide protective immunity. Nevertheless, two DNA vaccines were recently licensed for use in animals (horse and fish), underscoring the potential of this technology. Here, we describe recent advances in increasing the potency of these vaccines, in understanding their immunological mechanisms, and in their applications and efficacy in clinical trials so far.

References

Jul 2, 2004·Nature Biotechnology·Kendall Powell
Aug 5, 2004·Proceedings of the National Academy of Sciences of the United States of America·Freda K StevensonJason Rice
Sep 3, 2004·Proceedings of the National Academy of Sciences of the United States of America·G HermansonP Hobart
Dec 9, 2004·Molecular Therapy : the Journal of the American Society of Gene Therapy·Shulin LiAnjana Bhardwaj
Jan 15, 2005·Journal of Virology·Chunfu ZhengSylvia van Drunen Littel-van den Hurk
Mar 10, 2005·Marine Biotechnology·Erwin A RamosCelia Aurora T Torres-Villanueva
Mar 11, 2005·Expert Review of Vaccines·Liz HaygreenPete Kaiser
Mar 23, 2005·Proceedings of the National Academy of Sciences of the United States of America·Daniel P WebsterAdrian V S Hill
Jul 26, 2005·Proceedings of the National Academy of Sciences of the United States of America·He ZhouRalph A Reisfeld
Aug 23, 2005·Molecular Therapy : the Journal of the American Society of Gene Therapy·Andreas BråveBritta Wahren

❮ Previous
Next ❯

Citations

Mar 5, 2009·Cancer Immunology, Immunotherapy : CII·Catherine L RileyRobert C Rees
Apr 12, 2007·Wiener medizinische Wochenschrift·Giovanni AlmanzarBeatrix Grubeck-Loebenstein
Sep 3, 2011·Pharmaceutical Research·Tomoaki KurosakiHitoshi Sasaki
Apr 22, 2008·Veterinary Research Communications·K DhamaA Rai
Dec 3, 2013·Indian Journal of Virology : an Official Organ of Indian Virological Society·Sami UllahNosheen Riaz
Apr 30, 2010·Expert Reviews in Molecular Medicine·Neetu SinghSuresh K Mittal
Mar 12, 2009·Molecular Therapy : the Journal of the American Society of Gene Therapy·Mark WallaceLuwy Musey
Apr 2, 2009·Molecular Therapy : the Journal of the American Society of Gene Therapy·Sarfraz AhmadGerald C O'Sullivan
Jan 5, 2007·Viral Immunology·Jodie M HarrisonIan A Ramshaw
Jan 19, 2008·Clinical Microbiology Reviews·Donald P McManus, Alex Loukas
Mar 8, 2008·The Journal of Clinical Investigation·Godwin NchindaRalph M Steinman
Dec 13, 2007·Microbial Cell Factories·Zhijun WangAlicja Wegrzyn
Jan 8, 2011·Molecular Cancer·Azam BolhassaniSima Rafati
Dec 6, 2007·Genome Biology·Karl J ClarkScott C Fahrenkrug
Sep 17, 2013·Drug Design, Development and Therapy·Xiaoyun HongWeien Yuan
May 3, 2014·Science Translational Medicine·Shaden KamhawiJesus G Valenzuela
Jan 29, 2013·Nature Materials·Peter C DeMuthDarrell J Irvine
Jan 30, 2010·Expert Review of Vaccines·Joana A CarvalhoGabriel A Monteiro
Apr 6, 2007·Expert Review of Vaccines·Shaw-Wei D TsenT-C Wu
May 11, 2010·Expert Review of Vaccines·Sylvia van Drunen Littel-van den Hurk, D Hannaman
Oct 27, 2007·Expert Opinion on Biological Therapy·Alain LuxembourgDrew Hannaman
Jun 26, 2013·Current Opinion in Biotechnology·K M A GartlandY Akbarova
May 3, 2011·Current Opinion in Immunology·Niranjan Y Sardesai, David B Weiner
Sep 2, 2010·Biologicals : Journal of the International Association of Biological Standardization·Yun-Zhou YuZhi-Wei Sun

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimalarial Agents (ASM)

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Avian Influenza: Innate Immune Adjuvant (ASM)

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Anthrax Vaccines (ASM)

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

Avian Influenza: Innate Immune Adjuvant

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.

Anthrax

Anthrax toxin, comprising protective antigen, lethal factor, and oedema factor, is the major virulence factor of Bacillus anthracis, an agent that causes high mortality in humans and animals. Here is the latest research on Anthrax.

Antimalarial Agents

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Anthrax Vaccines

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.